Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TELA US Equity

TELA Bio, Inc.Health Care · Surgical & Medical Instruments & Apparatus · CIK 1561921 · FY ends Dec 31
$0.65
+0.00 (+0.62%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by SILVERARC CAPITAL MANAGEMENT, LLCsec.gov ↗
2026-08-138-K 5.02Departure/election of directors or officers; compensation (amendment)sec.gov ↗
2026-08-1113GSchedule 13G filed — ≥5% beneficial owner (passive) · by SILVERARC CAPITAL MANAGEMENT, LLCsec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-04

Every row is a filed document, checked against its EDGAR index.